Immunomodulatory effects of nivolumab and ipilimumab in combination or nivolumab monotherapy in advanced melanoma patients: CheckMate 038

被引：4
|
作者：
Ribas, Antoni
Martin-Algarra, Salvador
Bhatia, Shailender
Hwu, Wen-Jen
Slingluff, Craig L.
Sharfman, William H.
Hodi, F. Stephen
Urba, Walter J.
Luke, Jason J.
Haanen, John B.
Callahan, Margaret K.
Wolchok, Jedd D.
Chasalow, Scott D.
Ross-Macdonald, Petra
Young, Tina C.
Qureshi, Anila
Horak, Christine E.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT073
引用
收藏
页数：3
相关论文
共 50 条
  • [1] HEALTHCARE COST COMPARISON ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA
    Potluri, R.
    Bhandari, H.
    Ranjan, S.
    Moshyk, A.
    Kotapati, S.
    [J]. VALUE IN HEALTH, 2019, 22 : S72 - S73
  • [2] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Ravi Potluri
    Sandip Ranjan
    Hitesh Bhandari
    Helen Johnson
    Andriy Moshyk
    Srividya Kotapati
    [J]. Experimental Hematology & Oncology, 8
  • [3] Healthcare cost comparison analysis of nivolumab in combination with ipilimumab versus nivolumab monotherapy and ipilimumab monotherapy in advanced melanoma
    Potluri, Ravi
    Ranjan, Sandip
    Bhandari, Hitesh
    Johnson, Helen
    Moshyk, Andriy
    Kotapati, Srividya
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2019, 8 (1)
  • [4] COMPARISON OF HEALTHCARE COSTS IN FRANCE OF COMBINATION NIVOLUMAB AND IPILIMUMAB TREATMENT VERSUS NIVOLUMAB MONOTHERAPY AND IPILIMUMAB MONOTHERAPY IN ADVANCED MELANOMA
    Bregman, B.
    Moshyk, A.
    Johnson, H. M.
    Potluri, R.
    Bhandari, H.
    Ranjan, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S441 - S441
  • [5] Immunomodulatory activity of nivolumab monotherapy in patients with advanced melanoma
    Urba, Walter J.
    Martin-Algarra, Salvador
    Callahan, Margaret
    Wolchok, Jedd D.
    Sharfman, William H.
    Sosman, Jeffrey A.
    Bhatia, Shailender
    Hwu, Wen-Jen
    Gajewski, Thomas F.
    Slingluff, Craig L.
    Shen, Yun
    Horak, Christine E.
    Hodi, F. Stephen
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Nivolumab and Ipilimumab in Advanced Melanoma
    Ryu, Hyewon
    Lee, Hyo Jin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (25): : 2503 - 2503
  • [7] Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma
    Tetu, Pauline
    Mangana, Joanna
    Dummer, Reinhard
    Dutriaux, Caroline
    Beneton, Nathalie
    Dalle, Stephane
    Meyer, Nicolas
    Oriano, Bastien
    Michielin, Olivier
    Lebbe, Celeste
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 93 : 147 - 149
  • [8] PKPD relationship of ipilimumab plus nivolumab combination in patients with advanced melanoma
    Goldwirt, L.
    Louveau, B.
    Liv, T.
    Baroudjian, B.
    Allayous, C.
    Da Meda, L.
    Delyon, J.
    Sauvageon, H.
    Lebbe, C.
    Mourah, S.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 38 - 38
  • [9] Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
    Callahan, Margaret
    Amin, Asim
    Kaye, Frederic J.
    Morse, Michael A.
    Taylor, Matthew H.
    Peltola, Katriina J.
    Sharma, Padmanee
    OReilly, Eileen M.
    Shropshire, Stephanie Meadows
    OBrien, Shaun
    Tschaika, Marina
    Le, Dung T.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (02)
  • [10] Nico: Real World Evidence in Advanced Melanoma; A National Prospective Non-Interventional Study of Nivolumab Monotherapy or in Combination with Ipilimumab in Patients with Advanced Melanoma and in Patients with Adjuvant Nivolumab Therapy
    Schadendorf, Dirk
    Eigertler, Thomas
    Mohr, Peter
    Weichenthal, Michael
    Goeppner, Daniela
    Haferkamp, Sebastian
    Herber, Martin
    Meier, Friedegund
    Meiss, Frank
    Pfoehler, Claudia
    Schneider, Stefan W.
    Terheyden, Patrick
    Ulrich, Lens
    Utikal, Jochen
    Weishaupt, Carsten
    Gutzmer, Ralf
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 175 - 175
12345